These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37040554)

  • 21. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
    Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
    Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysplasia in inflammatory bowel disease.
    Greenson JK
    Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer.
    Murphy J; Kalkbrenner KA; Pemberton JH; Landmann RG; Heppell JP; Young-Fadok TM; Etzioni DA
    Dis Colon Rectum; 2014 Aug; 57(8):993-8. PubMed ID: 25003294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysplasia in ulcerative colitis--clinical consequences?
    Sjöqvist U
    Langenbecks Arch Surg; 2004 Oct; 389(5):354-60. PubMed ID: 15605166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysplasia and Cancer in Inflammatory Bowel Disease.
    Huang LC; Merchea A
    Surg Clin North Am; 2017 Jun; 97(3):627-639. PubMed ID: 28501251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for cancer prevention strategies in high-risk ulcerative colitis.
    Campbell FC; Maxwell RJ
    Surgeon; 2009 Apr; 7(2):96-100. PubMed ID: 19408802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis.
    Kasuga K; Yamada M; Shida D; Tagawa T; Takamaru H; Sekiguchi M; Sakamoto T; Uraoka T; Sekine S; Kanemitsu Y; Saito Y
    United European Gastroenterol J; 2021 Oct; 9(8):964-972. PubMed ID: 34232561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Management of Dysplasia and Cancer in Inflammatory Bowel Disease.
    Ansell J; Grass F; Merchea A
    Surg Clin North Am; 2019 Dec; 99(6):1111-1121. PubMed ID: 31676051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic Characteristics and Neoplasia Risk of Colorectal Inflammatory Polyposis in Inflammatory Bowel Disease.
    Ma YR; Polydorides AD
    Arch Pathol Lab Med; 2022 Jan; 146(2):172-181. PubMed ID: 33946102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
    Krugliak Cleveland N; Colman RJ; Rodriquez D; Hirsch A; Cohen RD; Hanauer SB; Hart J; Rubin DT
    Inflamm Bowel Dis; 2016 Mar; 22(3):631-7. PubMed ID: 26658214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal outcomes of the endoscopic resection of nonpolypoid dysplastic lesions in patients with inflammatory bowel disease.
    Kaltenbach T; Holmes I; Nguyen-Vu T; Malvar C; Balitzer D; Fong D; Fu A; Shergill A; McQuaid K; Soetikno R
    Gastrointest Endosc; 2023 May; 97(5):934-940. PubMed ID: 36649745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysplasia in inflammatory bowel diseases.
    Mescoli C; Albertoni L; D'incá R; Rugge M
    Dig Liver Dis; 2013 Mar; 45(3):186-94. PubMed ID: 22974564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis.
    Mathy C; Schneider K; Chen YY; Varma M; Terdiman JP; Mahadevan U
    Inflamm Bowel Dis; 2003 Nov; 9(6):351-5. PubMed ID: 14671483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of nonpolypoid (flat and depressed) colorectal neoplasms in screening for CRC in patients with IBD.
    Rutter MD
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):327-35. PubMed ID: 24975524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microscopic features of colorectal neoplasia in inflammatory bowel diseases.
    Bressenot A; Cahn V; Danese S; Peyrin-Biroulet L
    World J Gastroenterol; 2014 Mar; 20(12):3164-72. PubMed ID: 24696602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathology and Clinical Significance of Inflammatory Bowel Disease-Associated Colorectal Dysplastic Lesions.
    Harpaz N; Itzkowitz SH
    Gastroenterol Clin North Am; 2024 Mar; 53(1):133-154. PubMed ID: 38280745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motion - colonoscopic surveillance is more cost effective than colectomy in patients with ulcerative colitis: Arguments for the motion.
    Lashner BA
    Can J Gastroenterol; 2003 Feb; 17(2):119-21. PubMed ID: 12605250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.